Skip to main content
Premium Trial:

Request an Annual Quote

People in the News at Angle, Centogene, Prenetics, Biological Dynamics, Enalees

Angle: Joseph Eid

Liquid biopsy technology company Angle has appointed Joseph Eid as a nonexecutive director. Eid is a physician who is board certified in medical oncology, hematology, and internal medicine. He most recently served as chief medical officer and head of global drug development for Luzsana Biotechnology, a subsidiary of Jiangsu Hengrui Pharmaceutical. He has also previously held senior positions in clinical development and medical affairs at Bristol Myers Squibb, Merck, and Hoffman-La Roche.

Centogene: Florian Vogel

Florian Vogel will step down as chief process officer and member of the management board of Centogene, effective Feb. 28. Until 2018, he was the company's senior director of R&D. Centogene did not announce any plans for his replacement.

Prenetics Global: Bayju Thakar

Genomic and diagnostic testing firm Prenetics Global has appointed Bayju Thakar as CEO and a board member of subsidiary Prenetics EMEA, which serves Europe, the Middle East, and Africa. Thakar has more than 20 years of experience in healthcare and digital health, mergers and acquisitions, and strategic partnerships, including as cofounder and CEO of Doctor Care Anywhere, a UK-based telehealth primary care business.

Biological Dynamics: Peter Wulff

Biological Dynamics has appointed Peter Wulff as its CFO, effective Jan. 1. He has more than 35 years of experience in financial management and was most recently CFO at JenaValve Technology. Before that he was the financial corporate officer at Alphatec Spine Holdings, Artes Medical, CryoCor, and Pure Biosciences. Based in San Diego, Biological Dynamics' ExoVerita platform isolates extracellular vesicles for multiomic applications.

Enalees: Eric Germain

Eric Germain has been appointed as managing director of French veterinary molecular diagnostics company Enalees. Previously, he held managing director and chief of staff roles at private and public institutions, including Genopole. Germain has a master's degree in biology from Université d'Orsay in Paris.

For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.